Skip to main content

BBIO

BridgeBio Pharma, Inc.

Company with tickers: BBIO

CIK
1743881
CUSIP
10806X102
Shares Outstanding
195,861,242
13F Activity (30d)
253 filings 248 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 462
Total Value: $15,301,719,657
Total Shares: 206,056,019
Showing 1–100 of 491 holdings by value · page 1 of 5

Institutional Ownership Trend

32 quarters

Holder Concentration

Across 462 13F filers
Top Holder
6.9%
Mar 2025 → Mar 2026 · range 6.9% – 13.9%
of institutional value
Top 5
30.0%
Mar 2025 → Mar 2026 · range 30.0% – 44.0%
of institutional value
Top 10
45.4%
Mar 2025 → Mar 2026 · range 45.4% – 61.5%
of institutional value
HHI
286
Mar 2025 → Mar 2026 · range 286 – 520
Broadly held

Quarterly Activity

vs Feb 12, 2026
New
461
Increased
0
Decreased
1
Sold Out
0
Unchanged
0
Holder count: +461
Institutional value: +1444.4%
Shares held: +1481.8%

Top Buyers

vs Feb 12, 2026
No qualifying movers this quarter.

Top Sellers

vs Feb 12, 2026
Institution Sold Now Holds Open

Top New Positions

vs Feb 12, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Feb 12, 2026
No fully closed positions this quarter.
Showing 100 of 491
Export CSV
Holder Value (USD) % of 13F Shares Open